EMEA-000810-PIP01-09 - paediatric investigation plan

grass pollen

rye pollen

birch pollen

Key facts

• Active Substance:
  • grass pollen
  • rye pollen
  • birch pollen
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/218/2010
• PIP number:
  EMEA-000810-PIP01-09
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  Treatment of allergic rhinitis / rhino-conjunctivitis
• Route(s) of administration:
  Subcutaneous use
• Contact for public enquiries:

  Allergy Therapeutics (UK) Ltd

  Tel. [phone]; E-mail: [e-mail]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  29/10/2010

Decision

P/218/2010: European Medicines Agency decision of 29 October 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for 12 grass pollen extract, cultiva...

AdoptedReference Number: EMA/615624/2010